Go back

Wellcome Trust sets up £200m biotech investment firm

The Wellcome Trust is to launch a business to invest in start-up healthcare and life sciences companies, it announced on 20 March.

The firm, which will get £200 million in initial capital from the Wellcome Trust, will be launched soon and is currently dubbed “Project Sigma”.

This article is only available to Research Professional News subscribers or Pivot-RP users.

If you are a Research Professional News subscriber you can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.